Category: Research

The Wisconsin Institutes for Discovery are a risky endeavor, Carl Gulbrandsen, managing director of the Wisconsin Alumni Research Foundation (WARF), acknowledged Tuesday.

Wisconsin discovered last week that being at the point of cutting-edge biological science such as embryonic stem cell research can be a two-edged sword. Two out-of-state foundations challenged the stem cell patents held by the Wisconsin Alumni Research Foundation.

A new single-crystal film of semiconductor developed at UW-Madison could lead to wearable electronics or computer monitors that roll up like a window shade.

The process of developing the super-thin layer, only a couple of hundred nanometers thick, is detailed in the current issue of the Journal of Applied Physics.

As Washington grappled last week with whether to ease restrictions on federal funding for embryonic stem cell research, two foundations launched an assault on Wisconsin’s embryonic stem cell patents.

Such a move, which was expected, is common when there are broad patents on a technology with so much potential, and it probably won’t be the last.

It also signaled increasing awareness among scientists and companies that the Wisconsin Alumni Research Foundation’s patents make this state the biggest interchange through which all stem cell commercialization must travel.

There are plenty of reasons to question the rationale for President’s Bush’s choice of the stem cell funding bill for his first presidential veto. We certainly disagree with the veto and question the message the President sends by making it his first. Never he less we respect the different opinions on this issue and feel it’s a debate worth having. And if the majority of Americans continue to support stem cell research, as polls indicate, eventually science will prevail.

Q: Were there ever any lyrics to taps — that sad melody that is usually sounded at military funerals?
A: Taps was one of many military service calls sounded on the bugle that helped structure the day for infantryman, said Susan Cook, a UW-Madison professor of music whose specialty is American music.

Madison, Wis. – Dr. Jamie Thomson and his colleagues at Madison’s WiCell Research Institute announced early this year they had developed two new lines of stem cells “fed” through a culture medium free of animal proteins. The breakthrough was hailed in scientific circles because it moved stem-cell research a step closer to clinical trials.

Wisconsin is a leader in stem cell research – UW Madison scientist James Thompson grew the first embryonic stem cells in 1998.Now, the UW says the President’s veto could shake Wisconsin’s leading status.

The US scientific community expressed frustration and disappointment yesterday at the announcement that President George W. Bush would veto bipartisan legislation to ease restrictions on embryonic stem cell research.

Madison: The Wisconsin Alumni Research Foundation is facing a challenge to 3 patents it owns on stem cell technology.

A California nonââ?¬â??profit group says 3 UW stem cell patents are a bigger hindrance to research than President Bush and his veto pen.

It’s perfectly normal for parents to send their child off to the grandma’s house for a couple of days, but it’s not normal for them to be as worried as Kevin and Ruth Shelly are about their daughter Maggie.

MADISON, Wis. ââ?¬â? The nation’s first bank of embryonic stem cells is thinking about outsourcing. The bank overseen by scientists at the University of Wisconsin is considering sending two new cell lines developed here to countries such as Australia and the United Kingdom where they can more easily be studied.

Madison, Wis. – The legal challenge to stem cell patents held by the Wisconsin Alumni Research Foundation has escalated the war of words between two states -Wisconsin and California – with both questioning the other’s financial motivations.

MADISON, Wis. — University of Wisconsin-Madison researchers said President George W. Bush dealt a major blow to embryonic stem cell research on Wednesday.

MADISON, Wis. — There’s an effort to overturn the embryonic stem cell patents held by the Wisconsin Alumni Research Foundation.

WASHINGTON // President Bush’s veto yesterday of a measure that would have expanded federal funding of research involving human embryonic stem cells promises to prolong years of sparring over whether the work promotes the destruction of life. But in many important ways, ethicists, researchers and even regulators within the Bush administration have moved past the political debate.

If you’ve driven through the UW Arboretum lately, you’ve probably seen them: several dozen black and white yard signs, all carrying the same message: “Protect the Arboretum. Stop the Developers.”

The developer in this case, as you may have heard, is Darren Kittleson. And the reason he’s persona non grata with members of the Arboretum Neighborhood Association is because he wants to build houses on two prime wooded lots and enlarge an old stone house on a third lot at the intersection of Arboretum Drive and Arboretum Lane.

In other words, smack dab in the middle of one of the most prized urban parklands and ecological research laboratories in America.

A California consumer watchdog group Tuesday asked the federal government to overturn three stem-cell patents held by the Wisconsin Alumni Research Foundation.

Reasonable voices in Congress from the left, middle and right agree on the need to encourage life-saving stem cell research.

WASHINGTON, July 18 � Following two days of often personal debate, the Senate defied a veto threat by President Bush on Tuesday and approved legislation that would expand federal support of medical research using embryonic stem cells.

A bill approved by the Senate yesterday to spur stem cell research would go a long way toward removing restrictions that have slowed progress, burdened laboratories with red tape, reduced American competitiveness and discouraged young researchers from entering the field, several leading stem cell scientists said.

John Lough wants to turn embryonic stem cells into beating heart muscle cells that someday might be transplanted into the damaged hearts of people.

Clive Svendsen is working to transform embryonic stem cells into engineered cells that can protect and repair the brain cells of people suffering from the neurological disorders amyotrophic lateral sclerosis (ALS) and Parkinson’s disease.

The two Wisconsin scientists and other researchers said that if legislation allowing for expanded federal funding for human embryonic stem cell research is enacted, it likely would be a boon to the promising field as well as their own research efforts.

A California-based consumer group and a stem cell scientist took action Tuesday to overturn the landmark patents on human embryonic stem cells held by the Wisconsin Alumni Research Foundation, claiming that the patents hinder research, drive scientists overseas and waste taxpayer money.

Yesterday’s Senate vote was the latest skirmish in an often rancorous eight-year-old battle over the science and ethics of embryonic stem cell research.

Three bills on stem-cell research, one of which would fundamentally shift federal science policy, passed the Senate on Tuesday afternoon after two of days of extensive, exhaustive, and contentious debate. The landmark bill — which passed 63 to 37, and which President Bush has vowed to veto — would relax the federal government’s tight limits on which embryonic-stem-cell lines are eligible for federally subsidized research.

Washington, D.C. – The United States Senate, by a vote of 63-37, has enacted a bill that would overturn President Bush’s ban on new federal funding for embryonic stem cell research, setting the stage for a promised presidential veto.

MADISON, Wis. — University of Wisconsin researchers and Gov. Jim Doyle applauded the U.S. Senate on Tuesday for passing a bill that lifts federal restrictions on stem-cell research. Both Wisconsin senators voted for the bill.

In a challenge to President Bush�s ban, the Senate passed a bill Tuesday that would allow federal money to be used for human embryonic stem cell research.

We know now that Abbas Ourmazd wasn’t the person to manage the ramp-up in research at the University of Wisconsin-Milwaukee after his overly public dust-up with his boss last week.

The U.S. Senate is expected to vote today on a bill on embryonic stem cell research of vital economic importance to Wisconsin and of equal importance to millions of people who suffer from a wide range of incurable and debilitating illnesses and conditions. The bill would loosen restrictions on federal dollars for such research, imposed five years ago by President Bush. The research was pioneered at the University of Wisconsin-Madison.

The developments are being closely followed in Wisconsin, because the University of Wisconsin-Madison campus, in the words of officials there, is a “world leader in the field.”

Ambiguous loss “is the most stressful loss,” writes Pauline Boss, an emertitus professor at the University of Minnesota who developed the concept and coined the term while a graduate student at the University of Wisconsin-Madison in the 1970s.

An emotion-charged debate opens Monday in the U.S. Senate on whether to unleash more federal dollars to fund research on embryonic stem cells.

The debate about embryonic stem cell research cuts across party lines in Wisconsin as much as in the rest of the country.

WASHINGTON, July 15 � Before Sept. 11 changed everything, President Bush wrestled publicly with the issue of embryonic stem cell research, then opened the door to federal financing for the science in the first major decision of his nascent administratio

The University of Wisconsin-Milwaukee was roiling in shock and confusion Thursday to news that its research czar had threatened to resign, with the administration sending mixed messages about whether the resignation was final and the rank and file expressing mixed feelings about leadership of the university.
Advertisement
72140UW-Milwaukee
Quotable

(Santiago) announced that the resignation had been tendered.

– Sally Lundeen,
College of Nursing
Recent Coverage
6/13/06: UWM vice chancellor threatens to resign
5/8/06: UWM touts its big ideas
3/17/06: Region lags in race for funding
3/5/06: Scientist helping take UWM to next level
1/13/06: UWM re-aims its research
Archive Coverage
Section: Education
Weblog: The School Zone

Q. What’s the best way to dispose of unused fishing bait?
A. It may seem counterintuitive, but the best thing to do with leftover bait is to fertilize the garden, says UW-Madison limnologist John Magnuson.

Abbas Ourmazd, vice chancellor of research and dean of the Graduate School at the University of Wisconsin-Milwaukee, is threatening to resign unless he receives more support from Chancellor Carlos Santiago.

Healthy older people who burn higher amounts of energy in their day-to-day activities are much less likely to die prematurely than those who have a more sedentary daily regimen, according to an intriguing new study.

It is believed to be the first longevity study to use a novel, physiological laboratory method to measure how much energy a person actually expends daily rather than relying on potentially erroneous self-reported exercise estimates.

The study, which involved researchers at the University of Wisconsin-Madison, included 302 healthy men and women aged 70 to 82 who were followed for about six years.

A research dog at the University of Wisconsin-Madison suffered and died after it was denied sufficient veterinary care, according federal inspection reports that detailed numerous problems with the care of research animals at the university.

The inspector, Dawn Barksdale of the U.S. Department of Agriculture, highlighted more than a dozen violations of animal protection regulations in inspection reports dated between April and July 2005.